FLORHAM PARK, N.J., Oct. 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, today announced that it had added to its commercial portfolio of ...

Below are the list of project associated with the Regenerative Medicine and Biomaterials theme. Please note that some projects are in collaboration with other themes ...

Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound(TM) Product from Sequence LifeScience, Inc.

(Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, today announced that it had added to its commercial portfolio of placental-derived advanced biomaterial products ...

The extracellular matrix (ECM) is a key element of tissues and organs. It maintains their structure and provides biochemical and mechanobiological signals to the cells, having a prominent role in ...

FLORHAM PARK, N.J., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) ("Celularity”), a regenerative and cellular medicine company, today announced that it had added to its commercial ...

We invite contributions from leading experts in dentistry, genetics, biomaterials, and tissue engineering to share their insights, research findings, and clinical experiences. The collection will ...